Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 10, 2010 - Issue 2
Submit an article Journal homepage
972
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Optimizing treatment of schizophrenia to minimize relapse

Ludovic Samalin Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
,
Olivier Blanc Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
&
Pierre-Michel Llorca Service de Psychiatrie, Centre Hospitalier Universitaire, Clermont-Ferrand, France. [email protected]
Pages 147-150 | Published online: 09 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cristina Cavezza, Meera Aurora & James R.P. Ogloff. (2013) The effects of an adherence therapy approach in a secure forensic hospital: a randomised controlled trial. The Journal of Forensic Psychiatry & Psychology 24:4, pages 458-478.
Read now
Luis San, Miquel Bernardo, Agustín Gómez & Mario Peña. (2013) Factors associated with relapse in patients with schizophrenia. International Journal of Psychiatry in Clinical Practice 17:1, pages 2-9.
Read now

Articles from other publishers (4)

L. Samalin, T. Charpeaud & P.-M. Llorca. (2014) Aripiprazole injectable à libération prolongée dans le traitement de maintenance de la schizophrénie. L'Encéphale 40:6, pages 487-494.
Crossref
Kelly Graziani Giacchero Vedana & Adriana Inocenti Miasso. (2014) The meaning of pharmacological treatment for schizophrenic patients. Revista Latino-Americana de Enfermagem 22:4, pages 670-678.
Crossref
Isabelle de Beauchamp, Diane Lévy-Chavagnat & Jean-Jacques Chavagnat. (2013) Éducation thérapeutique et schizophrénie : Quels buts ?. Actualités Pharmaceutiques 52:524, pages 8-13.
Crossref
Antonio J García-Ruiz, Lucía Pérez-Costillas, Ana C Montesinos, Javier Alcalde, Itziar Oyagüez & Miguel A Casado. (2012) Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses. Health Economics Review 2:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.